SCHEMBL1680852

SCHEMBL1680852

COc1ccc(Oc2cccc(COS(C)(=O)=O)c2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.52
KDM4E B2RXH2 1/20 0.52
ALDH1A1 P00352 1/20 0.52
HTT P42858 1/20 0.52
IDO1 P14902 2/20 0.47
AGXT P21549 2/20 0.47
PGR P06401 4/20 0.47
NR3C1 P04150 1/20 0.47
MAOB P27338 2/20 0.46
FFAR1 O14842 1/20 0.45
TAS2R14 Q9NYV8 1/20 0.45
LTA4H P09960 1/20 0.44
CYP19A1 P11511 1/20 0.43
APLNR P35414 1/20 0.43
TP53 P04637 1/20 0.43
PKM P14618 1/20 0.43
NFKB1 P19838 1/20 0.43
RAB9A P51151 1/20 0.43
NFKB2 Q00653 1/20 0.43
RELA Q04206 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15923224 0.89 FFAR1 (0.51) SMN1; SMN2KDM4EALDH1A1HTTFFAR1
SCHEMBL5636631 0.89 IDO1 (0.59) IDO1AGXTMAOBTAS2R14
SCHEMBL3593702 0.80 IDO1 (0.46) ALDH1A1IDO1AGXTMAOB
SCHEMBL5937187 0.79 APLNR (0.59) SMN1; SMN2HTTIDO1AGXTMAOB
SCHEMBL8063113 0.79 CA2 (0.45) KDM4EALDH1A1IDO1AGXTNR3C1
SCHEMBL6211173 0.78 IDO1 (0.61) IDO1AGXTMAOB
SCHEMBL20761720 0.78 PGR (0.50) SMN1; SMN2HTTPGRNR3C1FFAR1
SCHEMBL16097270 0.78 FFAR1 (0.46) IDO1AGXTMAOBFFAR1RAB9A
SCHEMBL5067887 0.77 CHRM2 (0.47) SMN1; SMN2IDO1AGXTMAOBFFAR1
SCHEMBL1662777 0.77 KDM4E (0.44) KDM4EALDH1A1IDO1AGXTNR3C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110195999-A1 NOVEL ANTIFUNGAL AGENT CONTAINING HETEROCYCLIC COMPOUND NAKAMOTO KAZUTAKA 2011-08-11 US disclosed
US-7932272-B2 Antifungal agent containing heterocyclic compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2011-04-26 US disclosed
US-20090227799-A1 Novel Antimalarial Agent Containing Heterocyclic Compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-09-10 US disclosed
US-20070105943-A1 Novel antifungal agent containing heterocyclic compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2007-05-10 US disclosed
EP-1782811-A1 NOVEL ANTIMALARIA AGENT CONTAINING HETEROCYCLIC COMPOUND Eisai R&D Management Co., Ltd. (JP) 2007-05-09 EP disclosed
EP-1669348-A1 NOVEL ANTIFUNGAL AGENT COMPRISING HETEROCYCLIC COMPOUND Eisai Co., Ltd. (JP) 2006-06-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110195999-A1 NOVEL ANTIFUNGAL AGENT CONTAINING HETEROCYCLIC COMPOUND ERG28, CYP51A1, XPO1 SMN1; SMN2 4831/4885KDM4E 3112/4885ALDH1A1 1677/4885
US-20090227799-A1 Novel Antimalarial Agent Containing Heterocyclic Compound XPO1, THPO, G6PD SMN1; SMN2 4683/4885KDM4E 3022/4885ALDH1A1 1926/4885
US-20070105943-A1 Novel antifungal agent containing heterocyclic compound ERG28, DPM1, CYP51A1 SMN1; SMN2 4814/4885KDM4E 3245/4885ALDH1A1 1459/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.